Eli Lilly (LLY) EV to CFO (2009 - 2026)
Eli Lilly (LLY) EV to CFO (2009 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to CFO |
| 1 |
Gsk |
96,436,181.12 Bn |
96,436,176.16 Bn |
7.76 Bn |
10.72 Mn |
| 2 |
Eli Lilly |
1,017.30 Bn |
1,012.01 Bn |
16.22 Bn |
49.41 |
| 3 |
Johnson & Johnson |
579.61 Bn |
557.55 Bn |
15.96 Bn |
24.38 |
| 4 |
AbbVie |
402.30 Bn |
392.96 Bn |
10.78 Bn |
18.51 |
| 5 |
Merck |
294.24 Bn |
288.59 Bn |
12.09 Bn |
16.13 |
| 6 |
Amgen |
191.82 Bn |
179.78 Bn |
5.87 Bn |
16.71 |
| 7 |
Gilead Sciences |
155.93 Bn |
148.21 Bn |
5.52 Bn |
13.72 |
| 8 |
Pfizer |
149.05 Bn |
136.28 Bn |
-1.21 Bn |
11.37 |
| 9 |
Bristol Myers Squibb |
116.33 Bn |
105.88 Bn |
8.07 Bn |
7.96 |
| 10 |
Novartis Ag |
112.59 Bn |
111.90 Bn |
- |
5.87 |
| Date | Value |
|---|
| Jun 12, 2026 |
49.41 |
| Jun 11, 2026 |
50.51 |
| Jun 10, 2026 |
49.44 |
| Jun 9, 2026 |
49.67 |
| Jun 8, 2026 |
49.91 |
| Jun 5, 2026 |
49.16 |
| Jun 4, 2026 |
48.89 |
| Jun 3, 2026 |
46.86 |
| Jun 2, 2026 |
46.35 |
| Jun 1, 2026 |
47.06 |
| May 29, 2026 |
48.00 |
| May 28, 2026 |
48.96 |
| May 27, 2026 |
47.04 |
| May 26, 2026 |
46.61 |
| May 22, 2026 |
46.26 |
| May 21, 2026 |
45.24 |
| May 20, 2026 |
44.21 |
| May 19, 2026 |
44.09 |
| May 18, 2026 |
42.92 |
| May 15, 2026 |
43.63 |
